Service & Software
Global Endocrine Disruptors Analysis Service Market Research Report 2025
- Jun 06, 25
- ID: 29967
- Pages: 90
- Figures: 82
- Views: 9
The global market for Endocrine Disruptors Analysis Service was valued at US$ 209 million in the year 2024 and is projected to reach a revised size of US$ 322 million by 2031, growing at a CAGR of 6.3% during the forecast period.
Endocrine Disruptors Analysis Service refers to a specialized scientific service that focuses on detecting, identifying, and evaluating substances capable of interfering with the endocrine system of organisms. This service employs advanced analytical techniques—such as mass spectrometry, high-performance liquid chromatography, and bioassays—to assess whether chemicals in various samples (including environmental pollutants, consumer products, food, water, or biological tissues) can disrupt hormone production, secretion, transport, binding, action, or metabolism. It involves comprehensive screening of potential endocrine disruptors (like phthalates, bisphenols, pesticides, or industrial chemicals), quantification of their concentrations, and evaluation of their biological impacts, often combining chemical analysis with toxicological assessments to determine the risk these substances pose to human health and ecosystems. By providing detailed insights into the presence and effects of endocrine disruptors, this service supports regulatory compliance, product safety assessment, environmental monitoring, and research into hormonal imbalances and related health issues.
The Endocrine Disruptors Analysis Service industry is currently witnessing several notable trends. With growing awareness about the potential harmful effects of endocrine - disrupting chemicals (EDCs) on both human health and the environment, the demand for these analysis services has been steadily increasing. Regulatory bodies around the world, such as the U.S. Environmental Protection Agency (EPA) and the European Chemicals Agency (ECHA), have been implementing more stringent regulations regarding the assessment of chemicals for their endocrine - disrupting potential. This has compelled industries, including pharmaceuticals, cosmetics, agriculture, and plastics, to seek reliable analysis services to ensure compliance. In terms of market size, it has been on an upward trajectory. This growth is not only driven by regulations but also by the rising public concern about the health implications associated with EDCs, which include developmental disorders, reproductive problems, and certain cancers. As a result, consumers are increasingly demanding safer products, pushing companies to test for and eliminate EDCs from their formulations. Technologically, there is a trend towards the development and adoption of more advanced and efficient screening methods. In vitro assays, like receptor binding assays and cell - based assays, are popular due to their high throughput and cost - effectiveness, and they currently dominate the market, accounting for over 60% of total revenue share. Additionally, efforts are being made to develop standardized testing protocols to address the current challenges of complexity and variability in the endocrine system and the lack of uniformity in testing methods. Geographically, the Asia - Pacific region is expected to experience the highest growth rate, buoyed by the expansion of its pharmaceutical and chemical industries and the increasing adoption of international testing guidelines.
This report aims to provide a comprehensive presentation of the global market for Endocrine Disruptors Analysis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Disruptors Analysis Service.
The Endocrine Disruptors Analysis Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endocrine Disruptors Analysis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine Disruptors Analysis Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Proteomics
ToxStrategies
Smithers
Fera Science
PerkinElmer
Intertek
Eurofins Scientific
Labcorp
Charles River Laboratories
LAUS
Staphyt
Xenometrix
Compliance Services International
Creative Bioarray
Segment by Type
Endocrine Disruption Screening
Endocrine Disruptor Assessment
Segment by Application
Enterprise
Individual
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocrine Disruptors Analysis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Endocrine Disruptors Analysis Service refers to a specialized scientific service that focuses on detecting, identifying, and evaluating substances capable of interfering with the endocrine system of organisms. This service employs advanced analytical techniques—such as mass spectrometry, high-performance liquid chromatography, and bioassays—to assess whether chemicals in various samples (including environmental pollutants, consumer products, food, water, or biological tissues) can disrupt hormone production, secretion, transport, binding, action, or metabolism. It involves comprehensive screening of potential endocrine disruptors (like phthalates, bisphenols, pesticides, or industrial chemicals), quantification of their concentrations, and evaluation of their biological impacts, often combining chemical analysis with toxicological assessments to determine the risk these substances pose to human health and ecosystems. By providing detailed insights into the presence and effects of endocrine disruptors, this service supports regulatory compliance, product safety assessment, environmental monitoring, and research into hormonal imbalances and related health issues.
The Endocrine Disruptors Analysis Service industry is currently witnessing several notable trends. With growing awareness about the potential harmful effects of endocrine - disrupting chemicals (EDCs) on both human health and the environment, the demand for these analysis services has been steadily increasing. Regulatory bodies around the world, such as the U.S. Environmental Protection Agency (EPA) and the European Chemicals Agency (ECHA), have been implementing more stringent regulations regarding the assessment of chemicals for their endocrine - disrupting potential. This has compelled industries, including pharmaceuticals, cosmetics, agriculture, and plastics, to seek reliable analysis services to ensure compliance. In terms of market size, it has been on an upward trajectory. This growth is not only driven by regulations but also by the rising public concern about the health implications associated with EDCs, which include developmental disorders, reproductive problems, and certain cancers. As a result, consumers are increasingly demanding safer products, pushing companies to test for and eliminate EDCs from their formulations. Technologically, there is a trend towards the development and adoption of more advanced and efficient screening methods. In vitro assays, like receptor binding assays and cell - based assays, are popular due to their high throughput and cost - effectiveness, and they currently dominate the market, accounting for over 60% of total revenue share. Additionally, efforts are being made to develop standardized testing protocols to address the current challenges of complexity and variability in the endocrine system and the lack of uniformity in testing methods. Geographically, the Asia - Pacific region is expected to experience the highest growth rate, buoyed by the expansion of its pharmaceutical and chemical industries and the increasing adoption of international testing guidelines.
This report aims to provide a comprehensive presentation of the global market for Endocrine Disruptors Analysis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocrine Disruptors Analysis Service.
The Endocrine Disruptors Analysis Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Endocrine Disruptors Analysis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endocrine Disruptors Analysis Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Proteomics
ToxStrategies
Smithers
Fera Science
PerkinElmer
Intertek
Eurofins Scientific
Labcorp
Charles River Laboratories
LAUS
Staphyt
Xenometrix
Compliance Services International
Creative Bioarray
Segment by Type
Endocrine Disruption Screening
Endocrine Disruptor Assessment
Segment by Application
Enterprise
Individual
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocrine Disruptors Analysis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Disruptors Analysis Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Endocrine Disruption Screening
1.2.3 Endocrine Disruptor Assessment
1.3 Market by Application
1.3.1 Global Endocrine Disruptors Analysis Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Enterprise
1.3.3 Individual
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Disruptors Analysis Service Market Perspective (2020-2031)
2.2 Global Endocrine Disruptors Analysis Service Growth Trends by Region
2.2.1 Global Endocrine Disruptors Analysis Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Endocrine Disruptors Analysis Service Historic Market Size by Region (2020-2025)
2.2.3 Endocrine Disruptors Analysis Service Forecasted Market Size by Region (2026-2031)
2.3 Endocrine Disruptors Analysis Service Market Dynamics
2.3.1 Endocrine Disruptors Analysis Service Industry Trends
2.3.2 Endocrine Disruptors Analysis Service Market Drivers
2.3.3 Endocrine Disruptors Analysis Service Market Challenges
2.3.4 Endocrine Disruptors Analysis Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Disruptors Analysis Service Players by Revenue
3.1.1 Global Top Endocrine Disruptors Analysis Service Players by Revenue (2020-2025)
3.1.2 Global Endocrine Disruptors Analysis Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Endocrine Disruptors Analysis Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Endocrine Disruptors Analysis Service Revenue
3.4 Global Endocrine Disruptors Analysis Service Market Concentration Ratio
3.4.1 Global Endocrine Disruptors Analysis Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Disruptors Analysis Service Revenue in 2024
3.5 Global Key Players of Endocrine Disruptors Analysis Service Head office and Area Served
3.6 Global Key Players of Endocrine Disruptors Analysis Service, Product and Application
3.7 Global Key Players of Endocrine Disruptors Analysis Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Disruptors Analysis Service Breakdown Data by Type
4.1 Global Endocrine Disruptors Analysis Service Historic Market Size by Type (2020-2025)
4.2 Global Endocrine Disruptors Analysis Service Forecasted Market Size by Type (2026-2031)
5 Endocrine Disruptors Analysis Service Breakdown Data by Application
5.1 Global Endocrine Disruptors Analysis Service Historic Market Size by Application (2020-2025)
5.2 Global Endocrine Disruptors Analysis Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Endocrine Disruptors Analysis Service Market Size (2020-2031)
6.2 North America Endocrine Disruptors Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Endocrine Disruptors Analysis Service Market Size by Country (2020-2025)
6.4 North America Endocrine Disruptors Analysis Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrine Disruptors Analysis Service Market Size (2020-2031)
7.2 Europe Endocrine Disruptors Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Endocrine Disruptors Analysis Service Market Size by Country (2020-2025)
7.4 Europe Endocrine Disruptors Analysis Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Disruptors Analysis Service Market Size (2020-2031)
8.2 Asia-Pacific Endocrine Disruptors Analysis Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Endocrine Disruptors Analysis Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Endocrine Disruptors Analysis Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocrine Disruptors Analysis Service Market Size (2020-2031)
9.2 Latin America Endocrine Disruptors Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Endocrine Disruptors Analysis Service Market Size by Country (2020-2025)
9.4 Latin America Endocrine Disruptors Analysis Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Disruptors Analysis Service Market Size (2020-2031)
10.2 Middle East & Africa Endocrine Disruptors Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Endocrine Disruptors Analysis Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Endocrine Disruptors Analysis Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Proteomics
11.1.1 Creative Proteomics Company Details
11.1.2 Creative Proteomics Business Overview
11.1.3 Creative Proteomics Endocrine Disruptors Analysis Service Introduction
11.1.4 Creative Proteomics Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.1.5 Creative Proteomics Recent Development
11.2 ToxStrategies
11.2.1 ToxStrategies Company Details
11.2.2 ToxStrategies Business Overview
11.2.3 ToxStrategies Endocrine Disruptors Analysis Service Introduction
11.2.4 ToxStrategies Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.2.5 ToxStrategies Recent Development
11.3 Smithers
11.3.1 Smithers Company Details
11.3.2 Smithers Business Overview
11.3.3 Smithers Endocrine Disruptors Analysis Service Introduction
11.3.4 Smithers Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.3.5 Smithers Recent Development
11.4 Fera Science
11.4.1 Fera Science Company Details
11.4.2 Fera Science Business Overview
11.4.3 Fera Science Endocrine Disruptors Analysis Service Introduction
11.4.4 Fera Science Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.4.5 Fera Science Recent Development
11.5 PerkinElmer
11.5.1 PerkinElmer Company Details
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer Endocrine Disruptors Analysis Service Introduction
11.5.4 PerkinElmer Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.5.5 PerkinElmer Recent Development
11.6 Intertek
11.6.1 Intertek Company Details
11.6.2 Intertek Business Overview
11.6.3 Intertek Endocrine Disruptors Analysis Service Introduction
11.6.4 Intertek Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.6.5 Intertek Recent Development
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Details
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific Endocrine Disruptors Analysis Service Introduction
11.7.4 Eurofins Scientific Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.7.5 Eurofins Scientific Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp Endocrine Disruptors Analysis Service Introduction
11.8.4 Labcorp Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.8.5 Labcorp Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Details
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories Endocrine Disruptors Analysis Service Introduction
11.9.4 Charles River Laboratories Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.9.5 Charles River Laboratories Recent Development
11.10 LAUS
11.10.1 LAUS Company Details
11.10.2 LAUS Business Overview
11.10.3 LAUS Endocrine Disruptors Analysis Service Introduction
11.10.4 LAUS Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.10.5 LAUS Recent Development
11.11 Staphyt
11.11.1 Staphyt Company Details
11.11.2 Staphyt Business Overview
11.11.3 Staphyt Endocrine Disruptors Analysis Service Introduction
11.11.4 Staphyt Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.11.5 Staphyt Recent Development
11.12 Xenometrix
11.12.1 Xenometrix Company Details
11.12.2 Xenometrix Business Overview
11.12.3 Xenometrix Endocrine Disruptors Analysis Service Introduction
11.12.4 Xenometrix Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.12.5 Xenometrix Recent Development
11.13 Compliance Services International
11.13.1 Compliance Services International Company Details
11.13.2 Compliance Services International Business Overview
11.13.3 Compliance Services International Endocrine Disruptors Analysis Service Introduction
11.13.4 Compliance Services International Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.13.5 Compliance Services International Recent Development
11.14 Creative Bioarray
11.14.1 Creative Bioarray Company Details
11.14.2 Creative Bioarray Business Overview
11.14.3 Creative Bioarray Endocrine Disruptors Analysis Service Introduction
11.14.4 Creative Bioarray Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.14.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endocrine Disruptors Analysis Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Endocrine Disruption Screening
1.2.3 Endocrine Disruptor Assessment
1.3 Market by Application
1.3.1 Global Endocrine Disruptors Analysis Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Enterprise
1.3.3 Individual
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endocrine Disruptors Analysis Service Market Perspective (2020-2031)
2.2 Global Endocrine Disruptors Analysis Service Growth Trends by Region
2.2.1 Global Endocrine Disruptors Analysis Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Endocrine Disruptors Analysis Service Historic Market Size by Region (2020-2025)
2.2.3 Endocrine Disruptors Analysis Service Forecasted Market Size by Region (2026-2031)
2.3 Endocrine Disruptors Analysis Service Market Dynamics
2.3.1 Endocrine Disruptors Analysis Service Industry Trends
2.3.2 Endocrine Disruptors Analysis Service Market Drivers
2.3.3 Endocrine Disruptors Analysis Service Market Challenges
2.3.4 Endocrine Disruptors Analysis Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endocrine Disruptors Analysis Service Players by Revenue
3.1.1 Global Top Endocrine Disruptors Analysis Service Players by Revenue (2020-2025)
3.1.2 Global Endocrine Disruptors Analysis Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Endocrine Disruptors Analysis Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Endocrine Disruptors Analysis Service Revenue
3.4 Global Endocrine Disruptors Analysis Service Market Concentration Ratio
3.4.1 Global Endocrine Disruptors Analysis Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endocrine Disruptors Analysis Service Revenue in 2024
3.5 Global Key Players of Endocrine Disruptors Analysis Service Head office and Area Served
3.6 Global Key Players of Endocrine Disruptors Analysis Service, Product and Application
3.7 Global Key Players of Endocrine Disruptors Analysis Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Endocrine Disruptors Analysis Service Breakdown Data by Type
4.1 Global Endocrine Disruptors Analysis Service Historic Market Size by Type (2020-2025)
4.2 Global Endocrine Disruptors Analysis Service Forecasted Market Size by Type (2026-2031)
5 Endocrine Disruptors Analysis Service Breakdown Data by Application
5.1 Global Endocrine Disruptors Analysis Service Historic Market Size by Application (2020-2025)
5.2 Global Endocrine Disruptors Analysis Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Endocrine Disruptors Analysis Service Market Size (2020-2031)
6.2 North America Endocrine Disruptors Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Endocrine Disruptors Analysis Service Market Size by Country (2020-2025)
6.4 North America Endocrine Disruptors Analysis Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endocrine Disruptors Analysis Service Market Size (2020-2031)
7.2 Europe Endocrine Disruptors Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Endocrine Disruptors Analysis Service Market Size by Country (2020-2025)
7.4 Europe Endocrine Disruptors Analysis Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endocrine Disruptors Analysis Service Market Size (2020-2031)
8.2 Asia-Pacific Endocrine Disruptors Analysis Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Endocrine Disruptors Analysis Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Endocrine Disruptors Analysis Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endocrine Disruptors Analysis Service Market Size (2020-2031)
9.2 Latin America Endocrine Disruptors Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Endocrine Disruptors Analysis Service Market Size by Country (2020-2025)
9.4 Latin America Endocrine Disruptors Analysis Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endocrine Disruptors Analysis Service Market Size (2020-2031)
10.2 Middle East & Africa Endocrine Disruptors Analysis Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Endocrine Disruptors Analysis Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Endocrine Disruptors Analysis Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Proteomics
11.1.1 Creative Proteomics Company Details
11.1.2 Creative Proteomics Business Overview
11.1.3 Creative Proteomics Endocrine Disruptors Analysis Service Introduction
11.1.4 Creative Proteomics Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.1.5 Creative Proteomics Recent Development
11.2 ToxStrategies
11.2.1 ToxStrategies Company Details
11.2.2 ToxStrategies Business Overview
11.2.3 ToxStrategies Endocrine Disruptors Analysis Service Introduction
11.2.4 ToxStrategies Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.2.5 ToxStrategies Recent Development
11.3 Smithers
11.3.1 Smithers Company Details
11.3.2 Smithers Business Overview
11.3.3 Smithers Endocrine Disruptors Analysis Service Introduction
11.3.4 Smithers Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.3.5 Smithers Recent Development
11.4 Fera Science
11.4.1 Fera Science Company Details
11.4.2 Fera Science Business Overview
11.4.3 Fera Science Endocrine Disruptors Analysis Service Introduction
11.4.4 Fera Science Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.4.5 Fera Science Recent Development
11.5 PerkinElmer
11.5.1 PerkinElmer Company Details
11.5.2 PerkinElmer Business Overview
11.5.3 PerkinElmer Endocrine Disruptors Analysis Service Introduction
11.5.4 PerkinElmer Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.5.5 PerkinElmer Recent Development
11.6 Intertek
11.6.1 Intertek Company Details
11.6.2 Intertek Business Overview
11.6.3 Intertek Endocrine Disruptors Analysis Service Introduction
11.6.4 Intertek Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.6.5 Intertek Recent Development
11.7 Eurofins Scientific
11.7.1 Eurofins Scientific Company Details
11.7.2 Eurofins Scientific Business Overview
11.7.3 Eurofins Scientific Endocrine Disruptors Analysis Service Introduction
11.7.4 Eurofins Scientific Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.7.5 Eurofins Scientific Recent Development
11.8 Labcorp
11.8.1 Labcorp Company Details
11.8.2 Labcorp Business Overview
11.8.3 Labcorp Endocrine Disruptors Analysis Service Introduction
11.8.4 Labcorp Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.8.5 Labcorp Recent Development
11.9 Charles River Laboratories
11.9.1 Charles River Laboratories Company Details
11.9.2 Charles River Laboratories Business Overview
11.9.3 Charles River Laboratories Endocrine Disruptors Analysis Service Introduction
11.9.4 Charles River Laboratories Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.9.5 Charles River Laboratories Recent Development
11.10 LAUS
11.10.1 LAUS Company Details
11.10.2 LAUS Business Overview
11.10.3 LAUS Endocrine Disruptors Analysis Service Introduction
11.10.4 LAUS Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.10.5 LAUS Recent Development
11.11 Staphyt
11.11.1 Staphyt Company Details
11.11.2 Staphyt Business Overview
11.11.3 Staphyt Endocrine Disruptors Analysis Service Introduction
11.11.4 Staphyt Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.11.5 Staphyt Recent Development
11.12 Xenometrix
11.12.1 Xenometrix Company Details
11.12.2 Xenometrix Business Overview
11.12.3 Xenometrix Endocrine Disruptors Analysis Service Introduction
11.12.4 Xenometrix Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.12.5 Xenometrix Recent Development
11.13 Compliance Services International
11.13.1 Compliance Services International Company Details
11.13.2 Compliance Services International Business Overview
11.13.3 Compliance Services International Endocrine Disruptors Analysis Service Introduction
11.13.4 Compliance Services International Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.13.5 Compliance Services International Recent Development
11.14 Creative Bioarray
11.14.1 Creative Bioarray Company Details
11.14.2 Creative Bioarray Business Overview
11.14.3 Creative Bioarray Endocrine Disruptors Analysis Service Introduction
11.14.4 Creative Bioarray Revenue in Endocrine Disruptors Analysis Service Business (2020-2025)
11.14.5 Creative Bioarray Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Endocrine Disruptors Analysis Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Endocrine Disruption Screening
Table 3. Key Players of Endocrine Disruptor Assessment
Table 4. Global Endocrine Disruptors Analysis Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Endocrine Disruptors Analysis Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Endocrine Disruptors Analysis Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Endocrine Disruptors Analysis Service Market Share by Region (2020-2025)
Table 8. Global Endocrine Disruptors Analysis Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Endocrine Disruptors Analysis Service Market Share by Region (2026-2031)
Table 10. Endocrine Disruptors Analysis Service Market Trends
Table 11. Endocrine Disruptors Analysis Service Market Drivers
Table 12. Endocrine Disruptors Analysis Service Market Challenges
Table 13. Endocrine Disruptors Analysis Service Market Restraints
Table 14. Global Endocrine Disruptors Analysis Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Endocrine Disruptors Analysis Service Market Share by Players (2020-2025)
Table 16. Global Top Endocrine Disruptors Analysis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruptors Analysis Service as of 2024)
Table 17. Ranking of Global Top Endocrine Disruptors Analysis Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Endocrine Disruptors Analysis Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Endocrine Disruptors Analysis Service, Headquarters and Area Served
Table 20. Global Key Players of Endocrine Disruptors Analysis Service, Product and Application
Table 21. Global Key Players of Endocrine Disruptors Analysis Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Endocrine Disruptors Analysis Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Endocrine Disruptors Analysis Service Revenue Market Share by Type (2020-2025)
Table 25. Global Endocrine Disruptors Analysis Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Endocrine Disruptors Analysis Service Revenue Market Share by Type (2026-2031)
Table 27. Global Endocrine Disruptors Analysis Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Endocrine Disruptors Analysis Service Revenue Market Share by Application (2020-2025)
Table 29. Global Endocrine Disruptors Analysis Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Endocrine Disruptors Analysis Service Revenue Market Share by Application (2026-2031)
Table 31. North America Endocrine Disruptors Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Endocrine Disruptors Analysis Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Endocrine Disruptors Analysis Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Endocrine Disruptors Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Endocrine Disruptors Analysis Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Endocrine Disruptors Analysis Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Endocrine Disruptors Analysis Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Endocrine Disruptors Analysis Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Endocrine Disruptors Analysis Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Endocrine Disruptors Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Endocrine Disruptors Analysis Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Endocrine Disruptors Analysis Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Endocrine Disruptors Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Endocrine Disruptors Analysis Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Endocrine Disruptors Analysis Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Creative Proteomics Company Details
Table 47. Creative Proteomics Business Overview
Table 48. Creative Proteomics Endocrine Disruptors Analysis Service Product
Table 49. Creative Proteomics Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 50. Creative Proteomics Recent Development
Table 51. ToxStrategies Company Details
Table 52. ToxStrategies Business Overview
Table 53. ToxStrategies Endocrine Disruptors Analysis Service Product
Table 54. ToxStrategies Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 55. ToxStrategies Recent Development
Table 56. Smithers Company Details
Table 57. Smithers Business Overview
Table 58. Smithers Endocrine Disruptors Analysis Service Product
Table 59. Smithers Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 60. Smithers Recent Development
Table 61. Fera Science Company Details
Table 62. Fera Science Business Overview
Table 63. Fera Science Endocrine Disruptors Analysis Service Product
Table 64. Fera Science Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 65. Fera Science Recent Development
Table 66. PerkinElmer Company Details
Table 67. PerkinElmer Business Overview
Table 68. PerkinElmer Endocrine Disruptors Analysis Service Product
Table 69. PerkinElmer Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 70. PerkinElmer Recent Development
Table 71. Intertek Company Details
Table 72. Intertek Business Overview
Table 73. Intertek Endocrine Disruptors Analysis Service Product
Table 74. Intertek Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 75. Intertek Recent Development
Table 76. Eurofins Scientific Company Details
Table 77. Eurofins Scientific Business Overview
Table 78. Eurofins Scientific Endocrine Disruptors Analysis Service Product
Table 79. Eurofins Scientific Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 80. Eurofins Scientific Recent Development
Table 81. Labcorp Company Details
Table 82. Labcorp Business Overview
Table 83. Labcorp Endocrine Disruptors Analysis Service Product
Table 84. Labcorp Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 85. Labcorp Recent Development
Table 86. Charles River Laboratories Company Details
Table 87. Charles River Laboratories Business Overview
Table 88. Charles River Laboratories Endocrine Disruptors Analysis Service Product
Table 89. Charles River Laboratories Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 90. Charles River Laboratories Recent Development
Table 91. LAUS Company Details
Table 92. LAUS Business Overview
Table 93. LAUS Endocrine Disruptors Analysis Service Product
Table 94. LAUS Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 95. LAUS Recent Development
Table 96. Staphyt Company Details
Table 97. Staphyt Business Overview
Table 98. Staphyt Endocrine Disruptors Analysis Service Product
Table 99. Staphyt Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 100. Staphyt Recent Development
Table 101. Xenometrix Company Details
Table 102. Xenometrix Business Overview
Table 103. Xenometrix Endocrine Disruptors Analysis Service Product
Table 104. Xenometrix Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 105. Xenometrix Recent Development
Table 106. Compliance Services International Company Details
Table 107. Compliance Services International Business Overview
Table 108. Compliance Services International Endocrine Disruptors Analysis Service Product
Table 109. Compliance Services International Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 110. Compliance Services International Recent Development
Table 111. Creative Bioarray Company Details
Table 112. Creative Bioarray Business Overview
Table 113. Creative Bioarray Endocrine Disruptors Analysis Service Product
Table 114. Creative Bioarray Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 115. Creative Bioarray Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Endocrine Disruptors Analysis Service Picture
Figure 2. Global Endocrine Disruptors Analysis Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Endocrine Disruptors Analysis Service Market Share by Type: 2024 VS 2031
Figure 4. Endocrine Disruption Screening Features
Figure 5. Endocrine Disruptor Assessment Features
Figure 6. Global Endocrine Disruptors Analysis Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Endocrine Disruptors Analysis Service Market Share by Application: 2024 VS 2031
Figure 8. Enterprise Case Studies
Figure 9. Individual Case Studies
Figure 10. Endocrine Disruptors Analysis Service Report Years Considered
Figure 11. Global Endocrine Disruptors Analysis Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Endocrine Disruptors Analysis Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Endocrine Disruptors Analysis Service Market Share by Region: 2024 VS 2031
Figure 14. Global Endocrine Disruptors Analysis Service Market Share by Players in 2024
Figure 15. Global Endocrine Disruptors Analysis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Endocrine Disruptors Analysis Service Revenue in 2024
Figure 17. North America Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Endocrine Disruptors Analysis Service Market Share by Country (2020-2031)
Figure 19. United States Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Endocrine Disruptors Analysis Service Market Share by Country (2020-2031)
Figure 23. Germany Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Endocrine Disruptors Analysis Service Market Share by Region (2020-2031)
Figure 31. China Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Endocrine Disruptors Analysis Service Market Share by Country (2020-2031)
Figure 39. Mexico Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Endocrine Disruptors Analysis Service Market Share by Country (2020-2031)
Figure 43. Turkey Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Creative Proteomics Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 47. ToxStrategies Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 48. Smithers Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 49. Fera Science Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 50. PerkinElmer Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 51. Intertek Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 52. Eurofins Scientific Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 53. Labcorp Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 54. Charles River Laboratories Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 55. LAUS Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 56. Staphyt Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 57. Xenometrix Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 58. Compliance Services International Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 59. Creative Bioarray Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Endocrine Disruptors Analysis Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Endocrine Disruption Screening
Table 3. Key Players of Endocrine Disruptor Assessment
Table 4. Global Endocrine Disruptors Analysis Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Endocrine Disruptors Analysis Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Endocrine Disruptors Analysis Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Endocrine Disruptors Analysis Service Market Share by Region (2020-2025)
Table 8. Global Endocrine Disruptors Analysis Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Endocrine Disruptors Analysis Service Market Share by Region (2026-2031)
Table 10. Endocrine Disruptors Analysis Service Market Trends
Table 11. Endocrine Disruptors Analysis Service Market Drivers
Table 12. Endocrine Disruptors Analysis Service Market Challenges
Table 13. Endocrine Disruptors Analysis Service Market Restraints
Table 14. Global Endocrine Disruptors Analysis Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Endocrine Disruptors Analysis Service Market Share by Players (2020-2025)
Table 16. Global Top Endocrine Disruptors Analysis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocrine Disruptors Analysis Service as of 2024)
Table 17. Ranking of Global Top Endocrine Disruptors Analysis Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Endocrine Disruptors Analysis Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Endocrine Disruptors Analysis Service, Headquarters and Area Served
Table 20. Global Key Players of Endocrine Disruptors Analysis Service, Product and Application
Table 21. Global Key Players of Endocrine Disruptors Analysis Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Endocrine Disruptors Analysis Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Endocrine Disruptors Analysis Service Revenue Market Share by Type (2020-2025)
Table 25. Global Endocrine Disruptors Analysis Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Endocrine Disruptors Analysis Service Revenue Market Share by Type (2026-2031)
Table 27. Global Endocrine Disruptors Analysis Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Endocrine Disruptors Analysis Service Revenue Market Share by Application (2020-2025)
Table 29. Global Endocrine Disruptors Analysis Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Endocrine Disruptors Analysis Service Revenue Market Share by Application (2026-2031)
Table 31. North America Endocrine Disruptors Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Endocrine Disruptors Analysis Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Endocrine Disruptors Analysis Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Endocrine Disruptors Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Endocrine Disruptors Analysis Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Endocrine Disruptors Analysis Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Endocrine Disruptors Analysis Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Endocrine Disruptors Analysis Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Endocrine Disruptors Analysis Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Endocrine Disruptors Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Endocrine Disruptors Analysis Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Endocrine Disruptors Analysis Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Endocrine Disruptors Analysis Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Endocrine Disruptors Analysis Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Endocrine Disruptors Analysis Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. Creative Proteomics Company Details
Table 47. Creative Proteomics Business Overview
Table 48. Creative Proteomics Endocrine Disruptors Analysis Service Product
Table 49. Creative Proteomics Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 50. Creative Proteomics Recent Development
Table 51. ToxStrategies Company Details
Table 52. ToxStrategies Business Overview
Table 53. ToxStrategies Endocrine Disruptors Analysis Service Product
Table 54. ToxStrategies Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 55. ToxStrategies Recent Development
Table 56. Smithers Company Details
Table 57. Smithers Business Overview
Table 58. Smithers Endocrine Disruptors Analysis Service Product
Table 59. Smithers Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 60. Smithers Recent Development
Table 61. Fera Science Company Details
Table 62. Fera Science Business Overview
Table 63. Fera Science Endocrine Disruptors Analysis Service Product
Table 64. Fera Science Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 65. Fera Science Recent Development
Table 66. PerkinElmer Company Details
Table 67. PerkinElmer Business Overview
Table 68. PerkinElmer Endocrine Disruptors Analysis Service Product
Table 69. PerkinElmer Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 70. PerkinElmer Recent Development
Table 71. Intertek Company Details
Table 72. Intertek Business Overview
Table 73. Intertek Endocrine Disruptors Analysis Service Product
Table 74. Intertek Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 75. Intertek Recent Development
Table 76. Eurofins Scientific Company Details
Table 77. Eurofins Scientific Business Overview
Table 78. Eurofins Scientific Endocrine Disruptors Analysis Service Product
Table 79. Eurofins Scientific Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 80. Eurofins Scientific Recent Development
Table 81. Labcorp Company Details
Table 82. Labcorp Business Overview
Table 83. Labcorp Endocrine Disruptors Analysis Service Product
Table 84. Labcorp Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 85. Labcorp Recent Development
Table 86. Charles River Laboratories Company Details
Table 87. Charles River Laboratories Business Overview
Table 88. Charles River Laboratories Endocrine Disruptors Analysis Service Product
Table 89. Charles River Laboratories Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 90. Charles River Laboratories Recent Development
Table 91. LAUS Company Details
Table 92. LAUS Business Overview
Table 93. LAUS Endocrine Disruptors Analysis Service Product
Table 94. LAUS Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 95. LAUS Recent Development
Table 96. Staphyt Company Details
Table 97. Staphyt Business Overview
Table 98. Staphyt Endocrine Disruptors Analysis Service Product
Table 99. Staphyt Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 100. Staphyt Recent Development
Table 101. Xenometrix Company Details
Table 102. Xenometrix Business Overview
Table 103. Xenometrix Endocrine Disruptors Analysis Service Product
Table 104. Xenometrix Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 105. Xenometrix Recent Development
Table 106. Compliance Services International Company Details
Table 107. Compliance Services International Business Overview
Table 108. Compliance Services International Endocrine Disruptors Analysis Service Product
Table 109. Compliance Services International Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 110. Compliance Services International Recent Development
Table 111. Creative Bioarray Company Details
Table 112. Creative Bioarray Business Overview
Table 113. Creative Bioarray Endocrine Disruptors Analysis Service Product
Table 114. Creative Bioarray Revenue in Endocrine Disruptors Analysis Service Business (2020-2025) & (US$ Million)
Table 115. Creative Bioarray Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 119. Authors List of This Report
List of Figures
Figure 1. Endocrine Disruptors Analysis Service Picture
Figure 2. Global Endocrine Disruptors Analysis Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Endocrine Disruptors Analysis Service Market Share by Type: 2024 VS 2031
Figure 4. Endocrine Disruption Screening Features
Figure 5. Endocrine Disruptor Assessment Features
Figure 6. Global Endocrine Disruptors Analysis Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Endocrine Disruptors Analysis Service Market Share by Application: 2024 VS 2031
Figure 8. Enterprise Case Studies
Figure 9. Individual Case Studies
Figure 10. Endocrine Disruptors Analysis Service Report Years Considered
Figure 11. Global Endocrine Disruptors Analysis Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Endocrine Disruptors Analysis Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Endocrine Disruptors Analysis Service Market Share by Region: 2024 VS 2031
Figure 14. Global Endocrine Disruptors Analysis Service Market Share by Players in 2024
Figure 15. Global Endocrine Disruptors Analysis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Endocrine Disruptors Analysis Service Revenue in 2024
Figure 17. North America Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 18. North America Endocrine Disruptors Analysis Service Market Share by Country (2020-2031)
Figure 19. United States Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. Canada Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Europe Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Endocrine Disruptors Analysis Service Market Share by Country (2020-2031)
Figure 23. Germany Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. France Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. U.K. Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Italy Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Russia Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Nordic Countries Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Asia-Pacific Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Endocrine Disruptors Analysis Service Market Share by Region (2020-2031)
Figure 31. China Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Japan Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. South Korea Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Southeast Asia Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. India Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Australia Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Latin America Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Endocrine Disruptors Analysis Service Market Share by Country (2020-2031)
Figure 39. Mexico Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Brazil Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Middle East & Africa Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Endocrine Disruptors Analysis Service Market Share by Country (2020-2031)
Figure 43. Turkey Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Saudi Arabia Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. UAE Endocrine Disruptors Analysis Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Creative Proteomics Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 47. ToxStrategies Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 48. Smithers Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 49. Fera Science Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 50. PerkinElmer Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 51. Intertek Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 52. Eurofins Scientific Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 53. Labcorp Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 54. Charles River Laboratories Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 55. LAUS Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 56. Staphyt Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 57. Xenometrix Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 58. Compliance Services International Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 59. Creative Bioarray Revenue Growth Rate in Endocrine Disruptors Analysis Service Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oil in Water Monitoring Sensor Market Research Report 2025
Jun 06, 25
Global Large LCD Display Market Research Report 2025
Jun 06, 25
Global Commercial LCD Monitor Market Research Report 2025
Jun 06, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232